AngioDynamics raises 2026 revenue guidance to $314M while advancing Med Tech growth (NASDAQ:ANGO)
Earnings Call Insights: AngioDynamics (ANGO) Q2 2026 Management View CEO James Clemmer stated that "we delivered strong results in the ...
Saturday, May 30, 2026
Tag: NASDAQANGO
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.